ICCC Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	1 776.00
Średni wolumen	7 173.00
Kapitalizacja rynkowa	39.84M
EPS	$0 ( 2024-02-27 )
Następna data zysków	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.85
ATR14	$0.0390 (0.76%)

Insider Trading

Date	Person	Action	Amount	type
2023-09-06	Tomsche David Scott	Buy	3 100	Common stock $0.10 per value per share
2023-06-28	Gathagan Bryan K.	Buy	15 000	Non-Qualified Stock Options (Right to buy)
2023-06-16	Gathagan Bryan K.	Buy	0
2023-03-14	Tomsche David Scott	Buy	100	Common Stock, $0.10 per value per share
2023-03-14	Tomsche David Scott	Buy	69	Common Stock, $0.10 per value per share

INSIDER POWER
100.00
Last 96 transactions
Buy: 315 997 \| Sell: 92 686

ImmuCell Corp Korelacja

10 Najbardziej pozytywne korelacje
SGBX	0.878
VTSI	0.858
CCBG	0.844
FULT	0.843
HAS	0.837
EBMT	0.831
AMSF	0.83
LSBK	0.825
AMTB	0.815
CFB	0.812

10 Najbardziej negatywne korelacje
TRMD	-0.803

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ImmuCell Corp Finanse

Annual	2023
Przychody:	$17.47M
Zysk brutto:	$3.87M (22.15 %)
EPS:	$-0.750

FY	2023
Przychody:	$17.47M
Zysk brutto:	$3.87M (22.15 %)
EPS:	$-0.750

FY	2022
Przychody:	$18.57M
Zysk brutto:	$7.65M (41.19 %)
EPS:	$-0.320

FY	2021
Przychody:	$19.24M
Zysk brutto:	$8.66M (44.98 %)
EPS:	$-0.0102

Financial Reports:

No articles found.

ImmuCell Corp

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.